Department of Clinical and Cardiology, São Paulo State University, UNESP, Botucatu, Brazil.
Horm Metab Res. 2010 Jun;42(7):496-501. doi: 10.1055/s-0030-1249651. Epub 2010 Mar 31.
Obesity is rampant in modern society and growth hormone (GH) could be useful as adjunct therapy to reduce the obesity-induced cardiovascular damage. To investigate GH effects on obesity, initially 32 male Wistar rats were divided into two groups (n=16): control (C) was fed standard-chow and water and hypercaloric (H) was fed hypercaloric chow and 30% sucrose in its drinking water. After 45 days, both C and H groups were divided into two subgroups (n=8): C+PL was fed standard-chow, water and received saline subcutaneously; C+GH was fed standard-chow, water, and received 2 mg/kg/day GH subcutaneously; H+PL was fed hypercaloric diet, 30% sucrose in its drinking water, and received saline subcutaneously; and H+GH was fed hypercaloric diet, 30% sucrose in its drinking water, and received GH subcutaneously. After 75 days of total experimental period, H+PL rats were considered obese, having higher body weight, body mass index, Lee-index, and atherogenic index (AI) compared to C+PL. Obesity was accompanied by enhanced myocardial lipid hydroperoxide (LH) and lactate dehydrogenase (LDH), as well of depressed energy expenditure (RMR) and oxygen consumption(VO (2))/body weight. H+GH rats had higher fasting RMR, as well as lower AI and myocardial LH than H+PL. Comparing C+GH with C+PL, despite no effects on morphometric parameters, lipid profile, myocardial LH, and LDH activity, GH enhanced fed RMR and myocardial pyruvate dehydrogenase. In conclusion, the present study brought new insights into the GH effects on obesity related cardiovascular damage demonstrating, for the first time, that GH regulated cardiac metabolic pathways, enhanced energy expenditure and improved the lipid profile in obesity condition. Growth hormone in standard fed condition also offered promising therapeutic value enhancing pyruvate-dehydrogenase activity and glucose oxidation in cardiac tissue, thus optimizing myocardial energy metabolism.
肥胖症在现代社会中十分普遍,生长激素(GH)作为辅助治疗方法可能有助于减轻肥胖引起的心血管损伤。为了研究 GH 对肥胖的影响,最初将 32 只雄性 Wistar 大鼠分为两组(n=16):对照组(C)喂食标准饲料和水,高热量组(H)喂食高热量饲料和其饮用水中的 30%蔗糖。45 天后,C 和 H 两组又分为两组(n=8):对照组(C+PL)喂食标准饲料和水,并接受皮下注射生理盐水;C+GH 组喂食标准饲料和水,并接受皮下注射 2mg/kg/天的 GH;高热量组(H+PL)喂食高热量饲料和其饮用水中的 30%蔗糖,并接受皮下注射生理盐水;H+GH 组喂食高热量饲料和其饮用水中的 30%蔗糖,并接受皮下注射 GH。经过 75 天的总实验期后,H+PL 大鼠被认为肥胖,其体重、体重指数、Lee 指数和致动脉粥样硬化指数(AI)均高于 C+PL。肥胖伴随着心肌脂质氢过氧化物(LH)和乳酸脱氢酶(LDH)的增加,以及能量消耗(静息代谢率,RMR)和耗氧量(VO₂/体重)的降低。H+GH 大鼠的空腹 RMR 较高,AI 和心肌 LH 较低。与 C+PL 相比,C+GH 对形态参数、血脂谱、心肌 LH 和 LDH 活性没有影响,但增强了进食后的 RMR 和心肌丙酮酸脱氢酶。综上所述,本研究深入研究了 GH 对肥胖相关心血管损伤的影响,首次表明 GH 调节了心脏代谢途径,增加了能量消耗,并改善了肥胖状态下的血脂谱。在标准喂养条件下,生长激素也具有很好的治疗价值,增强了心脏组织中丙酮酸脱氢酶的活性和葡萄糖氧化,从而优化了心肌能量代谢。